Authors: CHIJIOKE CP UMEH RE MBAH AU NWONU P FLECKENSTEIN LL OKONKWO PO

Citation: Cp. Chijioke et al., CLINICAL PHARMACOKINETICS OF SURAMIN IN PATIENTS WITH ONCHOCERCIASIS, European Journal of Clinical Pharmacology, 54(3), 1998, pp. 249-251

Authors: LI QG PEGGINS JO FLECKENSTEIN LL MASONIC K HEIFFER MH BREWER TG

Citation: Qg. Li et al., THE PHARMACOKINETICS AND BIOAVAILABILITY OF DIHYDROARTEMISININ, ARTEETHER, ARTEMETHER, ARTESUNIC ACID AND ARTELINIC ACID IN RATS, Journal of Pharmacy and Pharmacology, 50(2), 1998, pp. 173-182

Authors: CATNEY CM ARTHUR CL FLECKENSTEIN LL SCAVONE JM

Citation: Cm. Catney et al., MODEL FOR CLINICAL CLERKSHIP SITE DEVELOPMENT IN THE VISITING NURSE ASSOCIATION, American journal of pharmaceutical education, 62(2), 1998, pp. 156-161

Authors: SHERWOOD JA GACHIHI GS MUIGAI RK SKILLMAN DR MUGO M RASHID JR WASUNNA KMA WERE JBO KASILI SK MBUGUA JM KIRIGI G SCHAEFER KU OSTER CN FLECKENSTEIN LL BERMAN JD BREWER TG ROBERTS CR JOHNSON AJ SCHUSTER BG

Citation: Ja. Sherwood et al., PHASE-2 EFFICACY TRIAL OF AN ORAL 8-AMINOQUINOLINE (WR6026) FOR TREATMENT OF VISCERAL LEISHMANIASIS, Clinical infectious diseases, 19(6), 1994, pp. 1034-1039